Le Lézard
Classified in: Health, Sports and recreation
Subjects: PDT, DIS, LGB, NTA, DEI

Canada's 2SLGBTQI+ Community Resource Directory Helps Folks Find Support, Safer Spaces


TORONTO, June 22, 2023 /CNW/ - It's Pride season and what better way to celebrate than with the launch of Canada's newest 2SLGBTQI+ community resource directory, created by IN Magazine.

The IN Directory is a national community resource directory for 2SLGBTQI+ specific programs, services and supports currently featuring 325 community resource listings across all 10 provinces and three territories: from St. John's to Victoria, Iqaluit to Windsor, and everywhere in between.

Visitors can access the directory in a grid or map view and filter search results by province, city/town, category (i.e., community programs; health care; mental health and addictions; trans; crisis and helplines; employment, education and training; housing, emergency housing and shelters; sexual health; youth; abuse and assault; arts and culture; people with disabilities; children and family services; legal; African, Caribbean and Black; faith and spirituality; Indigenous peoples; older adults; Francophones; newcomers; and sport and recreation) and keyword search.

Each community resource listing contains a detailed overview of 2SLGBTQI+ specific programs, services and supports offered by organizations and service providers and contact information including a website, phone and/or text support number and social media handles.

"We know that 2SLGBTQI+ Canadians are more likely to be victims of violent crimes like hate crimes, more likely to experience poor mental health outcomes and to be diagnosed with a mood or anxiety disorder and more likely to have seriously contemplated suicide in their lifetimes," says Jumol Royes, IN's director of communications and community engagement.

"The need for trusted information sources to help folks find support and safer spaces is greater than ever. This digital directory will serve as a living resource navigation tool that is continually expanded and updated in partnership with diverse 2SLGBTQI+ communities."

The IN Directory is co-created by IN Magazine ? Canada's leading 2SLGBTQI+ digital publication, website and community platform ? and 2SLGBTQI+ community members, and proudly sponsored by Pride Parenthood with Anova Fertility and Reproductive Health.

Visit: inmagazine.ca/directory 

About IN Magazine

IN Magazine is Canada's leading 2SLGBTQI+ digital publication, website and community platform celebrating Canada's 2SLGBTQI+ communities. IN Magazine is published by Elevate Media Group, a full-service creative agency that helps brands and the communities they serve through authentic marketing grounded in purpose, with a focus on 2SLGBTQI+ communities. www.inmagazine.ca    

SOURCE Elevate Media Group


These press releases may also interest you

18 mai 2024
Celltrion partners with TV star Mollie Pearce to launch the second installation of the Where's Crohn's & Colitis (CC)? campaign for this year's World IBD Day (19 May 2024). The campaign focuses on access to IBD care and treatment as the burden of...

18 mai 2024
On Wednesday, May 15, Red Door Community hosted their annual Celebrating Women Working and Living with Cancer Luncheon at the Metropolitan Club in New York City. The event raised more than $300,000 while shining a light on the women who inspire us...

18 mai 2024
Product: Kalihim (Philippine Bread Roll) Issue: Food - Allergen - Egg Distribution: British Columbia See the affected products and product photos for this recall SOURCE Canadian Food Inspection Agency (CFIA)

18 mai 2024
The global industrial automation market in life sciences industry  size is estimated to grow by USD 5.06 bn from 2024-2028, according to Technavio. The market is estimated to grow at a CAGR of  11.4%  during the forecast period. ...

18 mai 2024
Boston Scientific Corporation today announced positive six-month results from the ongoing pivotal MODULAR ATP clinical trial of the mCRMtm System,* the first modular cardiac rhythm management (CRM) system that consists of the EMBLEMtm Subcutaneous...

18 mai 2024
Gilead Sciences, Inc. , following the recent acquisition of CymaBay Therapeutics, Inc., today announced interim results from the ongoing ASSURE study demonstrating treatment with seladelpar, an investigational PPAR delta agonist, led to improvements...



News published on and distributed by: